The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum

Ananias A. Escalante; David L. Smith; Yuseob Kim

doi:10.1016/j.pt.2009.09.008

The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum

Ananias A. Escalante, David L. Smith, Yuseob Kim

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Abstract

The evolution of resistance in Plasmodium falciparum against safe and affordable drugs such as chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) is a major global health threat. Investigating the dynamics of resistance against these antimalarial drugs will lead to approaches for addressing the problem of resistance in malarial parasites that are solidly based in evolutionary genetics and population biology. In this article, we discuss current developments in population biology modeling and evolutionary genetics. Despite great advancements achieved in the past decade, understanding the complex dynamics of mutations conferring drug resistance in P. falciparum requires approaches that consider the parasite population structure among other demographic processes.

Original language	English (US)
Pages (from-to)	557-563
Number of pages	7
Journal	Trends in parasitology
Volume	25
Issue number	12
DOIs	https://doi.org/10.1016/j.pt.2009.09.008
State	Published - Dec 2009
Externally published	Yes

ASJC Scopus subject areas

Parasitology
Infectious Diseases

Access to Document

10.1016/j.pt.2009.09.008

Cite this

@article{03dcafba50d04ecaa065b932c5d193a7,

title = "The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum",

abstract = "The evolution of resistance in Plasmodium falciparum against safe and affordable drugs such as chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) is a major global health threat. Investigating the dynamics of resistance against these antimalarial drugs will lead to approaches for addressing the problem of resistance in malarial parasites that are solidly based in evolutionary genetics and population biology. In this article, we discuss current developments in population biology modeling and evolutionary genetics. Despite great advancements achieved in the past decade, understanding the complex dynamics of mutations conferring drug resistance in P. falciparum requires approaches that consider the parasite population structure among other demographic processes.",

author = "Escalante, {Ananias A.} and Smith, {David L.} and Yuseob Kim",

note = "Funding Information: This paper is based on a presentation at the conference on Anti-Malarial Drug Treatments organized by Research for the Future (RFF), Kruger National Park, South Africa, April 2008. RFF was supported by the grant 44811 from the Bill and Melinda Gates Foundation. This research is partially supported by the grant R01GM084320 (AE) from the National Institute of Health and DEB-0449581 (YK) from National Science Foundation. ",

year = "2009",

month = dec,

doi = "10.1016/j.pt.2009.09.008",

language = "English (US)",

volume = "25",

pages = "557--563",

journal = "Trends in parasitology",

issn = "1471-4922",

publisher = "Elsevier Limited",

number = "12",

}

TY - JOUR

T1 - The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum

AU - Escalante, Ananias A.

AU - Smith, David L.

AU - Kim, Yuseob

N1 - Funding Information: This paper is based on a presentation at the conference on Anti-Malarial Drug Treatments organized by Research for the Future (RFF), Kruger National Park, South Africa, April 2008. RFF was supported by the grant 44811 from the Bill and Melinda Gates Foundation. This research is partially supported by the grant R01GM084320 (AE) from the National Institute of Health and DEB-0449581 (YK) from National Science Foundation.

PY - 2009/12

Y1 - 2009/12

N2 - The evolution of resistance in Plasmodium falciparum against safe and affordable drugs such as chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) is a major global health threat. Investigating the dynamics of resistance against these antimalarial drugs will lead to approaches for addressing the problem of resistance in malarial parasites that are solidly based in evolutionary genetics and population biology. In this article, we discuss current developments in population biology modeling and evolutionary genetics. Despite great advancements achieved in the past decade, understanding the complex dynamics of mutations conferring drug resistance in P. falciparum requires approaches that consider the parasite population structure among other demographic processes.

AB - The evolution of resistance in Plasmodium falciparum against safe and affordable drugs such as chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) is a major global health threat. Investigating the dynamics of resistance against these antimalarial drugs will lead to approaches for addressing the problem of resistance in malarial parasites that are solidly based in evolutionary genetics and population biology. In this article, we discuss current developments in population biology modeling and evolutionary genetics. Despite great advancements achieved in the past decade, understanding the complex dynamics of mutations conferring drug resistance in P. falciparum requires approaches that consider the parasite population structure among other demographic processes.

UR - http://www.scopus.com/inward/record.url?scp=70449119849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449119849&partnerID=8YFLogxK

U2 - 10.1016/j.pt.2009.09.008

DO - 10.1016/j.pt.2009.09.008

M3 - Review article

C2 - 19864183

AN - SCOPUS:70449119849

SN - 1471-4922

VL - 25

SP - 557

EP - 563

JO - Trends in parasitology

JF - Trends in parasitology

IS - 12

ER -

The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this